Ustekinumab (anti-IL-12/IL-23)

製品コードA2024 別名: Stelara, CNTO 1275

For research use only.
Not for use in humans.

Ustekinumab (Stelara, CNTO 1275) is an anti-IL-12/IL-23 IgG1κ human monoclonal antibody used to treat psoriasis. MW=145.6 kDa.

Ustekinumab (anti-IL-12/IL-23)
サイズ 価格(税別)
5mg JPY 242300

代表番号: 03-5615-9297|電子メール:[email protected]
よく尋ねられる質問

質量管理及び製品安全説明書

Interleukins阻害剤の選択性比較

生物活性

製品説明 Ustekinumab (Stelara, CNTO 1275) is an anti-IL-12/IL-23 IgG1κ human monoclonal antibody used to treat psoriasis. MW=145.6 kDa.
体外試験

The addition of Ustekinumab (UST) significantly inhibits T follicular helper (TFH) cell differentiation in vitro.[1]

体内試験

Ustekinumab is generated via recombinant human IL-12 immunization of human Ig (hu-Ig) transgenic mice. Ustekinumab binds to the p40 subunit common to IL-12 and IL-23 and prevents their interaction with the IL-12 receptor β1 subunit of the IL-12 and IL-23 receptor complexes.[2]

お薦めの試験操作(参考用のみ)

細胞試験:
  • Objective: TFH cell differentiation assay
    Cells: naïve CD4+ T cells, T follicular helper (TFH) cells, PBMCs
    Concentrations: 100 ng/mL
    Incubation Time: 24 h
    Method: The TFH cell differentiation assay is performed with freshly isolated PBMCs from healthy donors (n = 16). Naïve CD4+ T cells are isolated by using the human Naïve CD4+ T Cell Isolation Kit II. A total of 500,000 naïve CD4+ T cells are cultured in complete medium in the presence of 12.5 μL/mL anti-CD3/CD28 in a flat-bottom 48 well plate. After 24 hours of culture, cytokines are added and cells are incubated for additional 2.5 days. A total of 5 ng/mL IL-12 + 5 ng/mL TGFβ with and without 100 ng/mL UST and 100 ng/mL UST alone are used.
    Reference: https://pubmed.ncbi.nlm.nih.gov/32679193

    Ustekinumab can apply to humanized mice, peripheral blood and other related assays (Only for Reference)

製品説明

CAS No. 815610-63-0
Formulation PBS, PH7.2
Isotype Human IgG1
Source Human
Storage Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles

技術サポート

ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

Handling Instructions

他に質問がある場合は、お気軽にお問い合わせください。

* 必須

大学・企業名を記入してください
名前を記入してください
電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
お問い合わせ内容をご入力ください
Tags: Ustekinumab (anti-IL-12/IL-23)を買う | Ustekinumab (anti-IL-12/IL-23) ic50 | Ustekinumab (anti-IL-12/IL-23)供給者 | Ustekinumab (anti-IL-12/IL-23)を購入する | Ustekinumab (anti-IL-12/IL-23)費用 | Ustekinumab (anti-IL-12/IL-23)生産者 | オーダーUstekinumab (anti-IL-12/IL-23) | Ustekinumab (anti-IL-12/IL-23)化学構造 | Ustekinumab (anti-IL-12/IL-23)分子量 | Ustekinumab (anti-IL-12/IL-23)代理店